FDA approves BeiGene’s Tevimbra plus chemo for oesophageal cancer

The FDA has approved BeiGene’s Tevimbra with chemotherapy for treating oesophageal squamous cell carcinoma.

Leave a Reply

Your email address will not be published. Required fields are marked *